Victory Capital Management Inc Dare Bioscience, Inc. Transaction History

Victory Capital Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.94 - $1.76 $145 - $272	-155 Reduced 1.34%	11,425 $14,000
Q1 2022 May 04, 2022	BUY	$1.42 - $2.09 $1,252 - $1,843	882 Added 8.24%	11,580 $13,000
Q4 2021 Feb 07, 2022	BUY	$1.42 - $2.13 $771 - $1,156	543 Added 5.35%	10,698 $21,000
Q3 2021 Nov 02, 2021	BUY	$1.42 - $2.0 $14,420 - $20,310	10,155 New	10,155 $17,000
Q2 2020 Aug 07, 2020	SELL	$0.84 - $1.11 $3,210 - $4,242	-3,822 Closed	0 $0

Q1 2020 May 04, 2020	BUY	$0.79 - $1.7 $595 - $1,281	754 Added 24.58%	3,822 $3,000
Q4 2019 Feb 04, 2020	BUY	$0.72 - $0.9 $353 - $441	491 Added 19.05%	3,068 $3,000
Q3 2019 Nov 12, 2019	BUY	$0.74 - $0.87 $1,906 - $2,241	2,577 New	2,577 $2,000

6.86M

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $28.8M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.